INMED PHARMACEUTICALS Correlations

MWG0 Stock   4.14  0.75  15.34%   
The current 90-days correlation between INMED PHARMACEUTICALS INC and Apple Inc is -0.04 (i.e., Good diversification). The correlation of INMED PHARMACEUTICALS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

INMED PHARMACEUTICALS Correlation With Market

Good diversification

The correlation between INMED PHARMACEUTICALS INC and DJI is -0.17 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding INMED PHARMACEUTICALS INC and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to INMED PHARMACEUTICALS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INMED PHARMACEUTICALS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INMED PHARMACEUTICALS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling INMED PHARMACEUTICALS INC to buy it.

Moving against INMED Stock

  0.41SSU Samsung ElectronicsPairCorr
  0.4SSUN Samsung ElectronicsPairCorr
  0.4SSUN Samsung ElectronicsPairCorr
  0.39SSU Samsung ElectronicsPairCorr
  0.35TCID Telkom Indonesia TbkPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between INMED Stock performing well and INMED PHARMACEUTICALS Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze INMED PHARMACEUTICALS's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
APC  0.88  0.27  0.21  1.34  0.89 
 1.81 
 4.97 
APC  0.85  0.26  0.19  0.94  0.98 
 1.88 
 5.24 
APC  0.86  0.26  0.22  0.75  0.84 
 2.06 
 4.50 
APC  0.93  0.27  0.18  15.95  1.04 
 2.22 
 6.45 
APC  0.95  0.28  0.24  5.15  0.74 
 2.83 
 5.24 
APC  0.84  0.27  0.21  1.52  1.00 
 1.88 
 6.46 
MSF  0.96  0.11  0.07  0.57  1.25 
 2.55 
 8.71 
MSF  1.05  0.11  0.06  1.51  1.38 
 2.35 
 9.11 
MSF  1.00  0.11  0.06  1.06  1.48 
 2.42 
 11.42 
MSF  0.92  0.11  0.06 (14.37) 1.33 
 2.04 
 8.79 

Be your own money manager

Our tools can tell you how much better you can do entering a position in INMED PHARMACEUTICALS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module